1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Products and Services 5.2.5 Competitive Rivalry within the Industry 6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 6.1 Drivers 6.1.1 Advancements in Stem Cell and Regenerative Medicine Research 6.1.2 Rising Incidences of Chronic Diseases 6.1.3 Advances in Drug Discovery and Development 6.1.4 R&D Funding and Investments by Government and Non-Governmental Organizations 6.2 Restraints 6.2.1 Regulatory Issues 6.2.2 Cost Constraints 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Equipment 7.1.1 Cryogenic Storage System 7.1.2 Refrigerator 7.1.3 Ice Machine 7.1.4 Freezer 7.1.5 Alarm Monitoring System 7.1.6 Others 7.2 By Media 7.2.1 Optimized Media 7.2.2 Non-Optimized Media 7.3 By Service 7.3.1 Human Tissue Biobanking 7.3.2 Stem Cell Biobanking 7.3.3 Cord Banking 7.3.4 DNA/RNA Biobanking 7.3.5 Others 7.4 By Application 7.4.1 Regenerative Medicine 7.4.2 Drug Discovery 7.4.3 Disease Research 7.5 By Geography 7.5.1 North America 7.5.1.1 United States 7.5.1.2 Canada 7.5.1.3 Mexico 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Atlanta Biologicals 9.2 Biolife Solutions 9.3 Bioniche Pharma USA LLC 9.4 Cell & Tissue Systems LLC 9.5 Essential Pharmaceuticals 9.6 Genzyme Corporation 9.7 Lifeline Scientific Inc. 9.8 Sigma Aldrich Corporation *List Not Exhaustive 10. Future of the Market 11. Disclaimer

Atlanta Biologicals, Inc., (Bio-Techne), Biolife Solutions, Inc., Bioniche Pharma USA LLC, Cell & Tissue Systems LLC, Essential Pharmaceuticals, Genzyme Corporation, Lifeline Scientific Inc., Sigma Aldrich Corporation